Johnson & Johnson in discussion with FDA regarding COVID-19 vaccine side effects | Inquirer News
Close  

Johnson & Johnson in discussion with FDA regarding COVID-19 vaccine side effects

/ 12:02 PM July 13, 2021
johnson and johnson vaccine

FILE PHOTO: A vial and sryinge are seen in front of a displayed Johnson & Johnson logo in this illustration taken January 11, 2021. REUTERS

Johnson & Johnson said on Monday it was in discussions with the U.S. Food and Drug Administration about rare cases of a neurological disorder, Guillain-Barré syndrome, that have been reported following vaccination with the Janssen COVID-19 vaccine.

The chance of having Guillain-Barré syndrome occur is very low and the rate of reported cases exceeds the background rate by a small degree, J&J said.

ADVERTISEMENT

The statement follows a Washington Post report on Monday, which said the FDA was expected to announce a new warning on J&J’s coronavirus vaccine related to a rare autoimmune disorder.

Guillain-Barré syndrome is a rare neurological disorder in which the body’s immune system mistakenly attacks part of its peripheral nervous system, or the network of nerves located outside of the brain and spinal cord.

FEATURED STORIES

RELATED STORIES

What you need to know about the Johnson & Johnson vaccine

US calls for pause on J&J’s COVID-19 jab after blood clotting cases

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: COVID-19 Vaccines, FDA, Health, Johnson and Johnson, side effects
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.